On 28 June 2019, orphan designation EU/3/19/2178 was granted by the European Commission to Dipharma B.V., The Netherlands, for sodium benzoate, sodium phenylacetate for the treatment of argininosuccinic aciduria.
|Disease / condition||
Treatment of argininosuccinic aciduria
|Date of first decision||
|EU designation number||
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: